| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30065498 | HIV | ENSG00000118432.13 | protein_coding | CNR1 | No | No | 1268 | P21554 S5TLS4 V5KA96 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CNR1 |
|---|---|
| DrugBank ID | DB00486 |
| Drug Name | Nabilone |
| Target ID | BE0000061 |
| UniProt ID | P21554 |
| Regulation Type | partial agonist |
| PubMed IDs | 17139494; 11698062; 8981483; 10575283; 8864542; 11752352 |
| Citations | Davis M, Maida V, Daeninck P, Pergolizzi J: The emerging role of cannabinoid neuromodulators in symptom management. Support Care Cancer. 2007 Jan;15(1):63-71. Epub 2006 Dec 1.@@Darmani NA: The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2. Eur J Pharmacol. 2001 Oct 26;430(1):49-58.@@Hirst RA, Almond SL, Lambert DG: Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist. Neurosci Lett. 1996 Dec 13;220(2):101-4.@@Pertwee RG: Cannabis and cannabinoids: pharmacology and rationale for clinical use. Forsch Komplementarmed. 1999 Oct;6 Suppl 3:12-5.@@Pertwee RG, Fernando SR: Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol. 1996 Aug;118(8):2053-8.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. |
| Groups | Approved; Investigational |
| Direct Classification | Naphthopyranones |
| SMILES | [H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC |
| Pathways | |
| PharmGKB | PA164746998 |
| ChEMBL | CHEMBL947 |
